Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.53B |
| 2 |
Eli Lilly
LLY
|
+$874M |
| 3 |
Blackstone
BX
|
+$706M |
| 4 |
RTX Corp
RTX
|
+$576M |
| 5 |
American Express
AXP
|
+$574M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.43B |
| 2 |
American Tower
AMT
|
+$1.25B |
| 3 |
Amazon
AMZN
|
+$785M |
| 4 |
TSS
Total System Services, Inc.
TSS
|
+$714M |
| 5 |
Apple
AAPL
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.49% |
| 2 | Financials | 15.09% |
| 3 | Technology | 13.78% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORTX
1126
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $11.2M | ﹤0.01% |
93,996
+7,696
| +9% | +$1.07M |
|
|
HNGR
1127
DELISTED
Hanger Inc.
HNGR
| $11.2M | ﹤0.01% |
547,532
-187,517
| -26% | -$3.52M |
|
|
NVMI
1128
Nova
NVMI
$12.4B
| $11.1M | ﹤0.01% |
350,563
-32,254
| -8% | -$917K |
|
1129
Cactus
WHD
$5.67B
| $11M | ﹤0.01% |
380,829
-49,468
| -11% | -$1.43M |
|
|
PRNB
1130
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $11M | ﹤0.01% |
389,582
-8,283
| -2% | -$304K |
|
1131
MGP Ingredients
MGPI
$369M
| $10.9M | ﹤0.01% |
220,358
-231,923
| -51% | -$13M |
|
|
IIN
1132
DELISTED
IntriCon Corporation
IIN
| $10.9M | ﹤0.01% |
561,866
+55,400
| +11% | +$1.07M |
|
1133
Insmed
INSM
$29.1B
| $10.9M | ﹤0.01% |
619,143
-19,447
| -3% | -$376K |
|
1134
Roper Technologies
ROP
$40.1B
| $10.9M | ﹤0.01% |
30,445
-41,337
| -58% | -$15M |
|
1135
QuidelOrtho
QDEL
$885M
| $10.8M | ﹤0.01% |
+176,758
| New | +$10.6M |
|
|
NPKI
1136
NPK International
NPKI
$1.15B
| $10.8M | ﹤0.01% |
1,413,637
-6,332
| -0.4% | -$44.8K |
|
1137
CNB Financial Corp
CCNE
$1.01B
| $10.8M | ﹤0.01% |
374,722
-5,833
| -2% | -$160K |
|
1138
OceanFirst Financial
OCFC
$1.87B
| $10.8M | ﹤0.01% |
455,596
+66,445
| +17% | +$1.55M |
|
1139
Magnite
MGNI
$3.46B
| $10.7M | ﹤0.01% |
1,233,254
-341,300
| -22% | -$2.99M |
|
1140
Shore Bancshares
SHBI
$784M
| $10.7M | ﹤0.01% |
695,353
-199,817
| -22% | -$3.15M |
|
|
YMAB
1141
DELISTED
Y-mAbs Therapeutics
YMAB
| $10.7M | ﹤0.01% |
+410,615
| New | +$10.5M |
|
|
FOE
1142
DELISTED
Ferro Corporation
FOE
| $10.7M | ﹤0.01% |
900,651
-2,814,971
| -76% | -$35.7M |
|
|
SPR
1143
DELISTED
Spirit AeroSystems
SPR
| $10.6M | ﹤0.01% |
129,100
+10,480
| +9% | +$821K |
|
1144
Scansource
SCSC
$1.1B
| $10.6M | ﹤0.01% |
347,400
-338,593
| -49% | -$10.5M |
|
1145
Red River Bancshares
RRBI
$648M
| $10.6M | ﹤0.01% |
243,995
+29,061
| +14% | +$1.33M |
|
1146
MVB Financial
MVBF
$386M
| $10.6M | ﹤0.01% |
531,494
-33,853
| -6% | -$609K |
|
1147
Matrix Service
MTRX
$329M
| $10.5M | ﹤0.01% |
613,988
-4,830
| -0.8% | -$90.9K |
|
|
HONE
1148
DELISTED
HarborOne Bancorp
HONE
| $10.5M | ﹤0.01% |
+1,039,426
| New | +$10.7M |
|
1149
Sierra Bancorp
BSRR
$516M
| $10.5M | ﹤0.01% |
393,542
-48,862
| -11% | -$1.26M |
|
|
CALA
1150
DELISTED
Calithera Biosciences, Inc
CALA
| $10.4M | ﹤0.01% |
168,734
-8,400
| -5% | -$672K |
|
Similar funds
Wellington Management Group's Q3 2019 Portfolio in Review
As of Q3 2019, Wellington Management Group held 2,207 positions worth $443B, down 1.8% from $452B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q3 2019 filing shows 166 new, 707 increased, 1,000 reduced and 194 closed positions. Its largest new stake was Cable One: 145,948 shares worth $183M. The largest sale was Allergan plc, an estimated $3.43B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q3 2019 buy was Cable One: 145,948 shares worth $183M.
- Wellington Management Group added most to Pfizer in Q3 2019, an estimated $1.53B increase.
- Wellington Management Group's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.43B.
- Wellington Management Group fully exited Total System Services, Inc. in Q3 2019, selling an estimated $714M.
- Wellington Management Group's ten largest holdings make up 15% of its $443B portfolio in Q3 2019.
- Wellington Management Group opened 166 new positions and closed 194 in Q3 2019.
- Wellington Management Group's portfolio value fell 1.8% quarter-over-quarter to $443B.
Based on Wellington Management Group's 13F filing for Q3 2019, filed 13 Nov 2019.